Bracco announces the birth of Bracco Japan Ltd Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

JPR 2023 A Bracco do Brasil estará no maior Congresso de Radiologia da América Latina com seu portfólio completo de soluções em Diagnóstico por Imagem.

Bracco è Marchio Storico di Interesse Nazionale L’azienda, nata nel 1927 e oggi leader globale nella diagnostica per immagini, entra a far parte dell’esclusivo gruppo di imprese storiche che rappresentano la punta di diamante del Made in Italy.

Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.